测量心力衰竭患者呼吸困难（SOB-HF）：一种新的呼吸困难评估工具的开发和验证。

Measuring shortness of breath in heart failure (SOB-HF): development and validation of a new dyspnoea assessment tool.

机构信息

Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Box 457, SE 405 30 Gothenburg, Sweden.

出版信息

Eur J Heart Fail. 2011 Aug;13(8):838-45. doi: 10.1093/eurjhf/hfr062.

DOI:10.1093/eurjhf/hfr062

PMID:21791539

Abstract

AIM

To validate a previously developed instrument for measurement of breathlessness in patients with acute heart failure (HF).

METHODS AND RESULTS

We tested descriptors of breathlessness among 190 patients seeking care at the emergency department (ED) for acute shortness of breath. Out of 115 patients with confirmed HF, 107 (94%) had dyspnoea as their main symptom. There were no significant differences between those patients with HF and those who were not diagnosed as heart failure (NHF) (n = 75) in the descriptors of breathlessness, although patients with HF scored significantly (P = 0.03) higher on a visual analogue scale (VAS). In addition, they had significantly (P = 0.03) higher breathing frequency than NHF patients and they were significantly (P < 0.001) more likely to be treated with >40 mg furosemide.

CONCLUSION

Assessment of acute dyspnoea using a VAS is useful in distinguishing HF from NHF, and may be a more valid approach as compared with using descriptors of intensity of breathlessness in the acute setting.

摘要

目的

验证先前开发的用于测量急性心力衰竭（HF）患者呼吸困难的工具。

方法和结果

我们在因急性呼吸急促而到急诊科就诊的 190 名患者中测试了呼吸困难的描述符。在 115 名确诊为 HF 的患者中，有 107 名（94%）以呼吸困难为主要症状。HF 患者与未被诊断为心力衰竭的患者（NHF；n=75）在呼吸困难描述符方面无显著差异，尽管 HF 患者的视觉模拟量表（VAS）评分显著更高（P=0.03）。此外，HF 患者的呼吸频率显著更高（P=0.03），且更有可能接受>40mg 呋塞米治疗。